NCT05702281View on ClinicalTrials.gov

Evaluation of the Safety and Efficacy of the ReLARC Inserter During the Insertion Procedure of GYNEFIX Intrauterine Copper Bearing Contraceptive Device with a Follow-up of 3 Years.

NARecruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions

Contraception

Interventions

DEVICE

ReLARC

ReLARC® is a GyneFix® device intended to be inserted via hysteroscopy. Hysteroscopic insertion of the device allows direct visualization of the procedure, which makes it extremely safe.

Trial Locations (1)

9000

RECRUITING

University Hospital, Ghent

All Listed Sponsors

collaborator

Federico II University

OTHER

lead

University Hospital, Ghent

OTHER